Sina Rashedi on Fibrinolytic Therapies in Different Thromboembolic Diseases
Sina Rashedi, Postdoctoral Research Fellow at Brigham and Women’s Hospital, Harvard Medical School, reposted from Behnood Bikdeli on X:
”Thrilled to share our recent JACC Journals
State-of-the-Art Review on fibrinolytic therapies for different thromboembolic diseases
Grateful to the outstanding experts I had the privilege to learn from and collaborate with on this paper!”
Read the full article in JACC.
Article: Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions
Authors: Sina Rashedi, Hannah Leyva, Nada Hamade, Mariana B. Pfeferman, Luis Ortega-Paz, Parham Sadeghipour, Azita H. Talasaz, Michelle L. O’Donoghue, David Jimenez, Manuel Monrea, Christopher D. Anderson, Mitchell S.V. Elkind, Irene M. Lang, Jeffery I. Weitz, Samuel Z. Goldhaber, Raffaele De Caterina, Stavros V. Konstantinides, Gregory Piazza, Harlan M. Krumholz, Eugene Braunwald, and Behnood Bikdeli
Behnood Bikdeli, Cardiologist and Vascular medicine specialist at Brigham and Women’s Hospital and Harvard Medical School, shared on X:
”Fibrinolytic therapies for cardiovascular conditions :
In JACC Journals we show current use, RCT data on MI, PE, DVT, stroke, and future directions!”
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Apr 6, 2026, 16:39Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
-
Apr 6, 2026, 16:38Linda Vorberg: A Detailed Analysis on The Usefulness of CT for DL-Based Stroke Lesion Segmentation
-
Apr 6, 2026, 16:37Colleen Hearn: Telestroke Helps Resource-Limited Facilities Gain Access to Unavailable Expertise
-
Apr 6, 2026, 16:37Nicolas Hubacz: AI Maps Neuroplasticity in Stroke Recovery – How the Brain Adapts After Injury
-
Apr 6, 2026, 16:36Cristina de Diego Alonso: Movement Is Not Just an Exercise, It Is The Rhythm of Daily Life
-
Apr 6, 2026, 16:35Charles Okyere Boadu: What Is The Most Likely Cause of Persistent Thrombocytopenia Despite Transfusion?
-
Apr 6, 2026, 16:34Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
-
Apr 6, 2026, 16:31Wolfgang Miesbach: New Real-World Data Reveal Ongoing Burden in Moderate-to-Severe Haemophilia A
-
Apr 6, 2026, 16:26Heghine Khachatryan։ Targeting High Risk Antiphospholipid Syndrome in Pregnancy with Hydroxychloroquine